| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |